Comparison 8. Oral misoprostol plus injectable uterotonics versus injectable uterotonics.

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 Severe postpartum haemorrhage (>= 1000 mL)	3		Risk Ratio (M‐H, Fixed, 95% CI)	Subtotals only
2 Postpartum haemorrhage (>= 500 mL)	3	3205	Risk Ratio (M‐H, Fixed, 95% CI)	0.71 [0.53, 0.95]
3 Blood loss (mL)	2		Mean Difference (IV, Fixed, 95% CI)	Subtotals only
4 Duration of third stage (mins)	1	788	Mean Difference (IV, Fixed, 95% CI)	0.10 [‐0.31, 0.51]
5 Third stage >= 30 minutes	1	788	Risk Ratio (M‐H, Fixed, 95% CI)	1.43 [0.24, 8.49]
6 Manual removal of placenta	2	2229	Odds Ratio (M‐H, Fixed, 95% CI)	0.93 [0.64, 1.35]
7 Blood transfusion	1	788	Risk Ratio (M‐H, Fixed, 95% CI)	0.37 [0.13, 1.02]
8 Vomiting	1	788	Risk Ratio (M‐H, Fixed, 95% CI)	0.95 [0.19, 4.68]
9 Diarrhoea	1	788	Risk Ratio (M‐H, Fixed, 95% CI)	1.03 [0.48, 2.23]
10 Any shivering	3		Risk Ratio (M‐H, Fixed, 95% CI)	Subtotals only
11 Pyrexia (>= 38 degrees C)	2	2022	Risk Ratio (M‐H, Fixed, 95% CI)	3.08 [1.80, 5.28]